Japan’s Omi Medical Center, Seikoukai, Becomes the First Healthcare Organization in Western Japan to Sign a Partnership Agreement with TriNetX to Increase Participation in Multi-National Clinical Trials

CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ — Omi Medical Center, part of the Seikoukai Social Medical Corporation and one of Japan’s leading institutions in the use of advanced medical technologies, announced it is partnering with TriNetX...

ConcertAI’s TeraRecon Integrates AI-based Chest Solutions into Eureka Clinical AI Platform through Riverain Technologies Partnership

Breadth and Depth of Integrations Across Lung Imaging Acquisition, Reading and Reporting, and Care Coordination Enhance Customer Workflow and Access CAMBRIDGE, Mass., Feb. 23, 2023 /PRNewswire/ — ConcertAI’s TeraRecon Eureka Clinical AI SaaS platform brings artificial intelligence (AI) and Deep Learning technologies to automate thoracic image interpretation...

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ — Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc for the treatment...